News Release

View printer-friendly version
<< Back

DURECT Corporation Presenting at the Rodman & Renshaw 3rd Annual Global Healthcare Conference


CUPERTINO, Calif., May 12 /PRNewswire-FirstCall/ -- DURECT Corporation (Nasdaq: DRRX) announced today that it will present a corporate overview at the Rodman & Renshaw 3rd Annual Global Healthcare Conference on Tuesday, May 16th at 2:40 p.m. CET. The conference is taking place at Le Meridien Beach Plaza Hotel in Monte Carlo, Monaco.

(Logo: http://www.newscom.com/cgi-bin/prnh/20020717/DRRXLOGO )

A live audio webcast of the presentation will be available by accessing DURECT's homepage at http://www.durect.com and clicking "Investor Relations."

About DURECT Corporation

DURECT Corporation is an emerging specialty pharmaceutical company focused on the development of pharmaceutical systems based on its proprietary drug delivery platform technologies. The company is developing pharmaceutical systems to deliver the right drug to the right place in the right amount at the right time to treat chronic and episodic diseases and conditions.

SOURCE DURECT Corporation
05/12/2006
CONTACT: Schond L. Greenway, Vice President, Investor Relations and Strategic Planning of DURECT Corporation, +1-408-777-1417
Photo: NewsCom: http://www.newscom.com/cgi-bin/prnh/20020717/DRRXLOGO
AP Archive: http://photoarchive.ap.org
PRN Photo Desk, photodesk@prnewswire.com
Web site: http://www.durect.com/
(DRRX)